The post BTS to Receive the Lullaby Treatment on New Rockabye Baby Album appeared first on Consequence. For a bedtime routine that’s smooth as butter, look no further than the new collection of ...

Roche's bispecific rivals are also looking to move Epkinly further up the treatment pathway, and Epkinly is being tested as a second-line option in the phase 3 EPCORE DLBCL-1 study, comparing it ...

If approved, mepolizumab could be the first biologic with monthly dosing for patients with COPD. Mepolizumab is currently approved for use in Europe across four IL-5 mediated conditions. These include ...

This growth is primarily driven by the recent entry of biologics into the treatment landscape and an increasing focus on precision medicine. A major catalyst in the COPD market has been the US ...

Background Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of ...

Adults with COPD who used inhaled corticosteroids for more than 24 months faced higher risks for diabetes, osteoporosis, ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...

COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment ...

Asthma and COPD share similar symptoms. Understanding the differences and similarities between the two conditions is important for effective diagnosis and treatment. Asthma and COPD both affect ...

The medication is approved for use alone or alongside other COPD treatments. Two clinical trials show that Ohtuvayre improved lung function and reduced flare-ups by 40% in patients with moderate to ...

Sanofi plans a phase 3 amlitelimab trial; safety remained consistent over 60 weeks of treatment ... in chronic obstructive pulmonary disease (COPD) will begin in 2025. In partnership with ...